These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31516531)

  • 41. [Clinical features and pathogenesis of anti-NMDA receptor encephalitis].
    Iizuka T
    Rinsho Shinkeigaku; 2008 Nov; 48(11):920-2. PubMed ID: 19198118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 43. An Infant Born to a Mother With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
    Chourasia N; Watkins MW; Lankford JE; Kass JS; Kamdar A
    Pediatr Neurol; 2018 Feb; 79():65-68. PubMed ID: 29310908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case report of anti-NMDA receptor encephalitis in a 24-year-old female: an uncommon presentation.
    Steeman A; Andriescu I; Sporcq C; Mathieu D; Meurant V; Mazairac G
    Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):79. PubMed ID: 35761962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis.
    Zhang M; Li W; Zhou S; Zhou Y; Yang H; Yu L; Wang J; Wang Y; Zhang L
    Front Neurol; 2019; 10():596. PubMed ID: 31244759
    [No Abstract]   [Full Text] [Related]  

  • 47. Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis.
    Yeshokumar AK; Sun LR; Klein JL; Baranano KW; Pardo CA
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27531146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
    Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
    JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and Outcomes of Epileptic Seizures in Mexican Pediatric Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Chavez-Castillo M; Ruiz-Garcia M; Herrera-Mora P
    Cureus; 2020 May; 12(5):e8211. PubMed ID: 32577329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case report of anti-N-methyl-D-aspartate receptor encephalitis in a middle-aged woman with a long history of major depressive disorder.
    Rong X; Xiong Z; Cao B; Chen J; Li M; Li Z
    BMC Psychiatry; 2017 Aug; 17(1):320. PubMed ID: 28859632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood‒brain barrier disruption in anti-NMDA receptor encephalitis.
    Chang H; Ma J; Feng K; Feng N; Wang X; Sun J; Guo T; Wei Y; Xu Y; Wang H; Yin L; Zhang X
    J Neuroinflammation; 2023 Jul; 20(1):172. PubMed ID: 37481571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Characteristics and Short-Term Prognosis of Autoimmune Encephalitis: A Single-Center Cohort Study in Changsha, China.
    Deng S; Qiu K; Liu H; Wu X; Lei Q; Lu W
    Front Neurol; 2019; 10():539. PubMed ID: 31178819
    [No Abstract]   [Full Text] [Related]  

  • 53. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 54. Psychiatric phenomena as initial manifestation of encephalitis by anti-NMDAR antibodies.
    Maat P; de Graaff E; van Beveren NM; Hulsenboom E; Verdijk RM; Koorengevel K; van Duijn M; Hooijkaas H; Hoogenraad C; Sillevis Smitt PA
    Acta Neuropsychiatr; 2013 Jun; 25(3):128-36. PubMed ID: 25287466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negative.
    Luykx JJ; Visscher R; Winter-van Rossum I; Waters P; de Witte LD; Fleischhacker WW; Lin BD; de Boer N; van der Horst M; Yeeles K; Davidson M; Pollak TA; Hasan A; Lennox BR
    Lancet Psychiatry; 2024 Oct; 11(10):828-838. PubMed ID: 39300641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testing for
    Brooks J; Yarbrough ML; Bucelli RC; Day GS
    Can J Neurol Sci; 2020 Jan; 47(1):69-76. PubMed ID: 31566162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The first case of Anti-N-methyl-d-aspartate receptor encephalitis (Anti-NMDAR encephalitis) associated with ovarian mucinous cystadenoma: A case report.
    Cho EH; Byun JM; Park HY; Kang MR; Jung YJ; Jeong CH; Kim YN; Lee KB; Sung MS; Jeong DH
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):557-559. PubMed ID: 31307751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-inflammatory cerebrospinal fluid delays the diagnosis and start of immunotherapy in anti-NMDAR encephalitis.
    Espinola-Nadurille M; Bautista-Gomez P; Flores J; Rivas-Alonso V; Perez-Esparza R; Solís-Vivanco R; Vargas-Cañas S
    Arq Neuropsiquiatr; 2018 Jan; 76(1):2-5. PubMed ID: 29364387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereotactic injection of cerebrospinal fluid from anti-NMDA receptor encephalitis into rat dentate gyrus impairs NMDA receptor function.
    Würdemann T; Kersten M; Tokay T; Guli X; Kober M; Rohde M; Porath K; Sellmann T; Bien CG; Köhling R; Kirschstein T
    Brain Res; 2016 Feb; 1633():10-18. PubMed ID: 26721688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Case of Severe Anti-N-Methyl D-Aspartate (Anti-NMDA) Receptor Encephalitis with Refractory Autonomic Instability and Elevated Intracranial Pressure.
    Salehi N; Yuan AK; Stevens G; Koshy R; Klein WF
    Am J Case Rep; 2018 Oct; 19():1216-1221. PubMed ID: 30310049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.